ScienceDaily
Your source for the latest research news
Follow Facebook Twitter LinkedIn Subscribe RSS Feeds Newsletters
New:
  • Hair Straightening Chemicals and Uterine Cancer
  • Ostriches With Similar Interests Form Groups
  • Cassini's Unique Observations of Saturn's Rings
  • Carnivorous Neanderthals
  • Dynamic Neolithic Social Networks
  • Giant Kangaroos: Long Reign of PNG's Megafauna
  • Soft, Flexible Robotics and Electronics
  • Clusters of Genes Help Mice Live Longer
  • A New Species of Deep-Sea Fish
  • 'Spiderweb' Star: Massive Rippling Dust Plumes
advertisement
Follow all of ScienceDaily's latest research news and top science headlines!
Science News
from research organizations

1

2

RNA-based therapy brings new hope for an incurable blood cancer

Date:
October 10, 2012
Source:
American Friends of Tel Aviv University
Summary:
A new class of drugs that interfere with the aggressive over-production of a protein related to Mantle Cell Lymphoma is being developed. The drugs have the ability to kill off the mutated protein and stop the over-proliferation of cells.
Share:
FULL STORY

Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed.

advertisement

One of the characteristics that defines MCL is heightened activity in the gene CCND1, which leads to the aggressive over-production of Cyclin D1, a protein that controls the proliferation of cells, explains Prof. Dan Peer of Tel Aviv University's Department of Cell Research and Immunology. In this disease, Cyclin D1 production spins out of control, producing a 3,000 to 5,000 fold increase.

Now, in an international collaboration between academia and industry, Prof. Peer has developed a new class of drugs based on RNA interference, which can repair or destroy faulty proteins and reprogram cells to act in normal ways. The drugs have the ability to kill off the mutated protein and stop the over-proliferation of cells. Their method, proven in experiments with human cells and published in the journal PLoS One, was generously supported by the Lewis Trust and the Israeli Science Foundation.

Academia and industry work for a cure

In the past, scientists have attempted and failed to knock out this protein in the quest to develop a cure for MCL. But despite the prevalent belief that Cyclin D1 is not an effective target for therapies, Prof. Peer and his fellow researchers, including his PhD student Shiri Weinstein and Dr. Rafi Emmanuel and the Sheba Medical Center's Prof. Arnon Nagler and Dr. Avigdor Abraham, knew there was cause for hope.

To prove their theory that Cyclin D1 was indeed an appropriate target for the treatment of MCL, the researchers turned to two companies considered world-experts in RNA, Alnylam Pharmaceuticals in Cambridge, Massachusetts and Integrated DNA Technologies in Iowa, both of which donated their time and resources to the project. Working in parallel, they were able to design potent RNA interference sequences to stop the production of Cyclin D1.

In MCL, Cyclin D1 is the exclusive cause of the over-production of B Lymphocytes, cells responsible for generating antibodies, explains Prof. Peer. This makes the protein a perfect target for RNA interference -- because normal, healthy cells don't express the gene, therapies that destroy the gene will only attack cancer cells. The RNA interference that the researchers have developed targets the faulty Cyclin D1 within the cancerous cells. And when the cells are inhibited from proliferating, they sense they are being targeted and begin to "commit suicide," he says.

In the lab, the researchers have successfully used their RNA interference in human cells, a crucial step towards proving that Cyclin D1 can be targeted through the right interventions. "Ultimately, we want to be able to cure this disease, and I think we are on the way," says Prof. Peer. He hopes that their results might cause scientists to reconsider previous and unproductive results on the effectiveness of treating MCL by addressing aberrations of this protein.

Pairing with nano-delivery methods

The researchers are working to develop a mouse population with MCL to test their newly-developed therapies in vivo. Typically, new therapies for any disease are tested on human cells as well as mouse models in the lab before being taken to clinical trials in humans. But there has never before been a test using mice with this disease, says Prof. Peer, a deficiency that has limited the quality of research. The animal test will allow researchers to conduct a more cautious and in-depth investigation of this new class of drugs before moving to the clinical stage.

As for strategies for delivering the new therapy into the body, the researchers will make use of Prof. Peer's extensive work with nano-sized medical "submarines" which are designed to travel to the source of disease or disorder in the human body, and offload drugs inside specific cells or proteins as needed.

make a difference: sponsored opportunity

Story Source:

Materials provided by American Friends of Tel Aviv University. Note: Content may be edited for style and length.


Journal Reference:

  1. Shiri Weinstein, Rafi Emmanuel, Ashley M. Jacobi, Avigdor Abraham, Mark A. Behlke, Andrew G. Sprague, Tatiana I. Novobrantseva, Arnon Nagler, Dan Peer. RNA Inhibition Highlights Cyclin D1 as a Potential Therapeutic Target for Mantle Cell Lymphoma. PLoS ONE, 2012; 7 (8): e43343 DOI: 10.1371/journal.pone.0043343

Cite This Page:

  • MLA
  • APA
  • Chicago
American Friends of Tel Aviv University. "RNA-based therapy brings new hope for an incurable blood cancer." ScienceDaily. ScienceDaily, 10 October 2012. <www.sciencedaily.com/releases/2012/10/121010131546.htm>.
American Friends of Tel Aviv University. (2012, October 10). RNA-based therapy brings new hope for an incurable blood cancer. ScienceDaily. Retrieved October 19, 2022 from www.sciencedaily.com/releases/2012/10/121010131546.htm
American Friends of Tel Aviv University. "RNA-based therapy brings new hope for an incurable blood cancer." ScienceDaily. www.sciencedaily.com/releases/2012/10/121010131546.htm (accessed October 19, 2022).

  • RELATED TOPICS
    • Health & Medicine
      • Lymphoma
      • Genes
      • Human Biology
      • Stem Cells
      • Immune System
      • Diseases and Conditions
      • Cancer
      • Leukemia
advertisement

  • RELATED TERMS
    • Chemotherapy
    • Antiviral drug
    • BRCA1
    • Lymphoma
    • Anti-obesity drug
    • Analgesic
    • Soy protein
    • Protein
advertisement

  Print   Email   Share

advertisement

1

2

3

4

5
Most Popular
this week

HEALTH & MEDICINE
Eating Late Increases Hunger, Decreases Calories Burned, and Changes Fat Tissue
Clusters of Genes Help Mice Live Longer
Healthy Aging Requires an Understanding of Personality Types
MIND & BRAIN
Dogs Can Smell When We're Stressed, Study Suggests
Human Brain Cells in a Dish Learn to Play Pong in Real Time
Eye-Opening Discovery About Adult Brain's Ability to Recover Vision
LIVING & WELL
Study of Over 5 Million People's DNA Reveals Genetic Links to Height
Did the Pandemic Change Our Personalities?
Watching TV With Your Child Can Help Their Cognitive Development, Study Suggests
advertisement

Strange & Offbeat
 

HEALTH & MEDICINE
RNA Origami Enables Applications in Synthetic Biology
Unlocking the Power of Our Emotional Memory
Robotic Drug Capsule Can Deliver Drugs to Gut
MIND & BRAIN
Human Brain Cells in a Dish Learn to Play Pong in Real Time
Dogs Can Smell When We're Stressed, Study Suggests
Dog-Human Bonds Could Guide Development of Social Robots
LIVING & WELL
Researchers Develop Painless Tattoos That Can Be Self-Administered
Washing Dishes With Superheated Steam More Effective, Earth-Friendly
News Addiction Linked to Not Only Poor Mental Wellbeing but Physical Health Too, New Study Shows
Explore More
from ScienceDaily

RELATED STORIES

T-Cells Could Be Made Into Better Cancer Killers by Increasing Their Protein Production
May 20, 2020 — Researchers have developed a technique to quantify protein production in immune cells known as T-cells, which typically target and kill cancer cells. However, when near a tumor, most T cells produce ...
Researchers Are Making Recombinant-Protein Drugs Cheaper
Apr. 23, 2020 — The mammalian cell lines that are engineered to produce high-value recombinant-protein drugs also produce unwanted proteins that push up the overall cost to manufacture these drugs. These same ...
A New Achilles' Heel of Blood Cancer
May 18, 2018 — Acute Myeloid Leukemia is an aggressive form of blood cancer. The diseased cells often carry mutated forms of a specific gene, which is known to function within large protein networks. Applying a ...
New Research Could Significantly Accelerate Drug Discovery
Jan. 17, 2018 — Many drugs work by inhibiting protein enzymes associated with a particular disease. Unfortunately, the same drugs can inhibit protein enzymes unrelated to the disease, resulting in harmful side ...
advertisement


SD
  • SD
    • Home Page
    • Top Science News
    • Latest News
  • Home
    • Home Page
    • Top Science News
    • Latest News
  • Health
    • View all the latest top news in the health sciences,
      or browse the topics below:
      Health & Medicine
      • Allergy
      • Alternative Medicine
      • Birth Control
      • Cancer
      • Diabetes
      • Diseases
      • Heart Disease
      • HIV and AIDS
      • Obesity
      • Stem Cells
      • ... more topics
      Mind & Brain
      • ADD and ADHD
      • Addiction
      • Alzheimer's
      • Autism
      • Depression
      • Headaches
      • Intelligence
      • Psychology
      • Relationships
      • Schizophrenia
      • ... more topics
      Living Well
      • Parenting
      • Pregnancy
      • Sexual Health
      • Skin Care
      • Men's Health
      • Women's Health
      • Nutrition
      • Diet and Weight Loss
      • Fitness
      • Healthy Aging
      • ... more topics
  • Tech
    • View all the latest top news in the physical sciences & technology,
      or browse the topics below:
      Matter & Energy
      • Aviation
      • Chemistry
      • Electronics
      • Fossil Fuels
      • Nanotechnology
      • Physics
      • Quantum Physics
      • Solar Energy
      • Technology
      • Wind Energy
      • ... more topics
      Space & Time
      • Astronomy
      • Black Holes
      • Dark Matter
      • Extrasolar Planets
      • Mars
      • Moon
      • Solar System
      • Space Telescopes
      • Stars
      • Sun
      • ... more topics
      Computers & Math
      • Artificial Intelligence
      • Communications
      • Computer Science
      • Hacking
      • Mathematics
      • Quantum Computers
      • Robotics
      • Software
      • Video Games
      • Virtual Reality
      • ... more topics
  • Enviro
    • View all the latest top news in the environmental sciences,
      or browse the topics below:
      Plants & Animals
      • Agriculture and Food
      • Animals
      • Biology
      • Biotechnology
      • Endangered Animals
      • Extinction
      • Genetically Modified
      • Microbes and More
      • New Species
      • Zoology
      • ... more topics
      Earth & Climate
      • Climate
      • Earthquakes
      • Environment
      • Geography
      • Geology
      • Global Warming
      • Hurricanes
      • Ozone Holes
      • Pollution
      • Weather
      • ... more topics
      Fossils & Ruins
      • Ancient Civilizations
      • Anthropology
      • Archaeology
      • Dinosaurs
      • Early Humans
      • Early Mammals
      • Evolution
      • Lost Treasures
      • Origin of Life
      • Paleontology
      • ... more topics
  • Society
    • View all the latest top news in the social sciences & education,
      or browse the topics below:
      Science & Society
      • Arts & Culture
      • Consumerism
      • Economics
      • Political Science
      • Privacy Issues
      • Public Health
      • Racial Disparity
      • Religion
      • Sports
      • World Development
      • ... more topics
      Business & Industry
      • Biotechnology & Bioengineering
      • Computers & Internet
      • Energy & Resources
      • Engineering
      • Medical Technology
      • Pharmaceuticals
      • Transportation
      • ... more topics
      Education & Learning
      • Animal Learning & Intelligence
      • Creativity
      • Educational Psychology
      • Educational Technology
      • Infant & Preschool Learning
      • Learning Disorders
      • STEM Education
      • ... more topics
  • Quirky
    • Top News
    • Human Quirks
    • Odd Creatures
    • Bizarre Things
    • Weird World
Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

  • Email Newsletters
  • RSS Feeds
Follow Us

Keep up to date with the latest news from ScienceDaily via social networks:

  • Facebook
  • Twitter
  • LinkedIn
Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

  • Leave Feedback
  • Contact Us
About This Site  |  Staff  |  Reviews  |  Contribute  |  Advertise  |  Privacy Policy  |  Editorial Policy  |  Terms of Use
Copyright 1995-2022 ScienceDaily or by other parties, where indicated. All rights controlled by their respective owners.
Content on this website is for information only. It is not intended to provide medical or other professional advice.
Views expressed here do not necessarily reflect those of ScienceDaily, its staff, its contributors, or its partners.
Financial support for ScienceDaily comes from advertisements and referral programs, where indicated.
— CCPA: Do Not Sell My Information — GDPR: Privacy Settings —